We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $268M
1-Year Est. Return 158.98%
This Fund
S&P 500
This Quarter Est. Return
+39.3%
1 Year Est. Return
+158.98%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$223M
AUM Growth
+$77.2M
Cap. Flow
+$48M
Cap. Flow %
21.55%
Top 10 Hldgs %
25.3%
Holding
464
New
223
Increased
67
Reduced
60
Closed
103

Sector Composition

1 Healthcare 52.36%
2 Technology 13.57%
3 Financials 11.27%
4 Communication Services 4.48%
5 Energy 3.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAC icon
51
Bank of America
BAC
$430B
$1.16M 0.52%
21,050
+11,959
+132% +$632K
ANIP icon
52
ANI Pharmaceuticals
ANIP
$1.8B
$1.13M 0.51%
14,320
+7,112
+99% +$616K
RLMD icon
53
Relmada Therapeutics
RLMD
$550M
$1.12M 0.5%
+231,123
New +$774K
LPG icon
54
Dorian LPG
LPG
$1.76B
$1.1M 0.49%
+45,131
New +$1.18M
C icon
55
Citigroup
C
$217B
$1.09M 0.49%
9,356
-2,010
-18% -$209K
CNTA
56
DELISTED
Centessa Pharmaceuticals
CNTA
$1.08M 0.49%
+43,266
New +$1.1M
VIK icon
57
Viking Holdings
VIK
$43.3B
$1.05M 0.47%
+14,773
New +$943K
CDTX
58
DELISTED
Cidara Therapeutics
CDTX
$1.04M 0.47%
+4,704
New +$760K
PACS icon
59
PACS Group
PACS
$7.3B
$1.03M 0.46%
+26,940
New +$591K
MYFW icon
60
First Western Financial
MYFW
$323M
$1.01M 0.45%
37,659
-948
-2% -$22.6K
TGTX icon
61
TG Therapeutics
TGTX
$8.4B
$990K 0.44%
33,212
+19,171
+137% +$626K
COLB icon
62
Columbia Banking Systems
COLB
$9.62B
$981K 0.44%
+35,083
New +$950K
PALI icon
63
Palisade Bio
PALI
$342M
$978K 0.44%
+416,035
New +$800K
IMCR icon
64
Immunocore
IMCR
$1.78B
$970K 0.44%
27,932
-683
-2% -$24.1K
CAPR icon
65
CALL
Capricor Therapeutics
CAPR
$1.13B
$964K 0.43%
831
+142
+21% +$1.85K
BIOA
66
BioAge Labs
BIOA
$1.01B
$963K 0.43%
+72,774
New +$645K
EXE
67
Expand Energy Corp
EXE
$21.1B
$928K 0.42%
+8,408
New +$932K
TFC icon
68
Truist Financial
TFC
$65.4B
$921K 0.41%
+18,710
New +$862K
NWS icon
69
News Corp Class B
NWS
$17.6B
$916K 0.41%
30,903
+3,390
+12% +$101K
UNH icon
70
UnitedHealth
UNH
$387B
$913K 0.41%
2,766
-9,297
-77% -$3.15M
CORT icon
71
Corcept Therapeutics
CORT
$9.72B
$899K 0.4%
+25,832
New +$2.03M
ETHA
72
iShares Ethereum Trust ETF
ETHA
$5.09B
$896K 0.4%
39,950
+6,732
+20% +$176K
BBIO icon
73
CALL
BridgeBio Pharma
BBIO
$15.9B
$868K 0.39%
376
+74
+25% +$4.86K
CNOB icon
74
Center Bancorp
CNOB
$1.68B
$862K 0.39%
32,890
-42,909
-57% -$1.09M
BSX icon
75
Boston Scientific
BSX
$65.4B
$834K 0.37%
+8,748
New +$858K

Similar funds

Persistent Asset Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Persistent Asset Partners held 464 positions worth $223M, up 53% from $145M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Persistent Asset Partners deployed $48M of net new capital in Q4 2025, opening 223 new positions and adding to 67 existing holdings. Its largest new stake was Molina Healthcare: 51,285 shares worth $8.9M.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 49% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was UnitedHealth, an estimated $3.15M trimmed.

  • Persistent Asset Partners's largest Q4 2025 buy was Molina Healthcare: 51,285 shares worth $8.9M.
  • Persistent Asset Partners added most to Elevance Health in Q4 2025, an estimated $5.15M increase.
  • Persistent Asset Partners's biggest Q4 2025 reduction was UnitedHealth, cutting an estimated $3.15M.
  • Persistent Asset Partners fully exited iShares 7-10 Year Treasury Bond ETF in Q4 2025, selling an estimated $4.82M.
  • Persistent Asset Partners's ten largest holdings make up 25% of its $223M portfolio in Q4 2025.
  • Persistent Asset Partners opened 223 new positions and closed 103 in Q4 2025.
  • Persistent Asset Partners's portfolio value rose 53% quarter-over-quarter to $223M.

Based on Persistent Asset Partners's 13F filing for Q4 2025, filed 17 Feb 2026.